14 insiders reported 56 Form 4 transactions for AN2 Therapeutics, Inc. (ANTX) over the past 18 months (most recent 2026-09-16). Recent activity: Trenor Cameron C. III (Chief Medical Officer) Buy 116,667 shares, Readnour Robin Shane (Director) Sell 523 shares, Readnour Robin Shane (Director) Sell 585 shares, Readnour Robin Shane (Director) Sell 2,877 shares, Readnour Robin Shane (Director) Sell 3,223 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Trenor Cameron C. III | Chief Medical Officer | Buy | 116,667 | $0 |
| 2026-09-11 | Readnour Robin Shane | Director | Sell | 523 | $3,151 |
| 2026-09-11 | Readnour Robin Shane | Director | Sell | 585 | $3,524 |
| 2026-09-08 | Readnour Robin Shane | Director | Sell | 2,877 | $17,463 |
| 2026-09-08 | Readnour Robin Shane | Director | Sell | 3,223 | $19,563 |
| 2026-09-08 | Readnour Robin Shane | Director | Sell | 4,725 | $28,436 |
| 2026-09-08 | Readnour Robin Shane | Director | Sell | 5,294 | $31,861 |
| 2026-09-04 | Williams Sarah Joanne | Principal Accounting Officer | Sell | 272 | $1,504 |
| 2026-09-02 | FitzPatrick Margaret M | Director | Buy | 2,098 | $11,602 |
| 2026-08-19 | Readnour Robin Shane | Director | Sell | 16,696 | $100,313 |
| 2026-08-19 | Readnour Robin Shane | Director | Sell | 18,706 | $112,389 |
| 2026-08-14 | Zakrzewski Joseph S | Director | Sell | 405,880 | $0 |
| 2026-07-10 | Aziz Kabeer | Director | Buy | 2,852 | $0 |
| 2026-07-10 | Martin Patricia A. | Director | Buy | 766 | $0 |
| 2026-07-10 | Marks Gilbert Lynn | Director | Buy | 2,789 | $0 |
| 2026-07-10 | Eizen Joshua M | See Remarks | Sell | 5,945 | $24,803 |
| 2026-06-02 | Williams Sarah Joanne | Principal Accounting Officer | Sell | 265 | $1,174 |
| 2026-04-10 | Aziz Kabeer | Director | Buy | 3,775 | $0 |
| 2026-04-10 | Martin Patricia A. | Director | Buy | 1,192 | $0 |
| 2026-04-10 | Marks Gilbert Lynn | Director | Buy | 3,775 | $0 |
| 2026-03-05 | Williams Sarah Joanne | Principal Accounting Officer | Sell | 327 | $347 |
| 2026-02-23 | Chanda Sanjay | Chief Development Officer | Buy | 38,000 | $0 |
| 2026-02-23 | Day Lucy | Chief Financial Officer | Buy | 38,000 | $0 |
| 2026-02-23 | Williams Sarah Joanne | Principal Accounting Officer | Buy | 48,375 | $0 |
| 2026-02-23 | Easom Eric | Chief Executive Officer | Buy | 112,250 | $0 |
Source: SEC Form 4 filings · as of 2026-09-16